Hide Board Information

Show Board Information

SITO Mobile, Ltd. SITOQ

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/30/2019 4:42:09 PM

Board Marks: 1

Posts Today: 0

Board Views Today: 1

SITO Mobile, Ltd. (OTCMRKTS: SITOQ) Stock Message Board

1. SITOQ Company Profile

    

2. SITOQ Time & Sales

    

3. SITOQ Recent News

    

4. SITOQ Filings

    

5. SITOQ Financials

    

6. SITOQ Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

6	SITO 21% v1,7M c.3230 f25M gap up and holding	znewcar1	12/30/2019 4:42:09 PM
5	New Management has made this nice Company turn	stock-scamper	03/18/2015 11:41:53 AM
4	SITO Financials 07/16/2014 09:54:54 Single Touch	Emylers	07/16/2014 10:54:51 AM
3	Latest Single Touch Systems (SITO) Headlines	Stock_Tracker	03/11/2014 8:57:38 AM
2	SITO 0.48 Stock Charts $SITO 1 Month Chart	chartguy89	03/09/2014 8:26:20 PM
1	SITO Stock Charts Last: UNCH Saturday, March 1,	chartguy89	03/01/2014 3:32:43 PM

Recent Articles

• Opportunity for Wolfspeed Investors to Pursue Class Action
• Kyverna Therapeutics Investors Alert Over Recent Class Action
• Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
• Urgent Alert for Symbotic Investors Regarding Class Action
• Investors Reminded of Key Deadline in PACS Group Lawsuits
• Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
• Important Update for Rentokil Investors on Class Action Lawsuit
• Important Update for Match Group Investors: Legal Actions Ahead
• Investors Urged to Act in Zeta Global Class Action Case
• Celsius Holdings Investors: Important Litigation Updates
• ASML Holding Class Action: Important Update for Investors
• Deadline Approaches for Hasbro Shareholders in Class Action
• Critical Update for Toronto-Dominion Bank Investors in Class Action
• Investors of Kyverna Therapeutics Can Pursue Class Action
• Xi Jinping Supports Hong Kong's Economic Strategies and Development
• Solar Alliance Energy Gains Shareholder Approval in Key Meeting
• Fruit Street Health Enhances Diabetes Prevention with Meals
• CNOOC Limited Partners with INEOS Energy in New Agreement
• Exciting Collaboration: Celebrate Japan's Fruit Culture
• Investors Urged to Act Before Deadline in Xiao-I Class Action
• Karma Sauce Applauds First We Feast's Bold New Direction
• Cassava Sciences Investors Encouraged to Act on Stock Losses
• Investors Warned of Upcoming Deadline in WM Technology Case
• Investors Urged to Act: Acadia Healthcare Class Action Deadline
• Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
• Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
• Legal Action Announced for Five9, Inc. Investors Following Stock Decline
• Legal Action Launched for Kyverna Therapeutics Investors
• Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
• Haloid Enhances Safety in Film Productions with Reviews
• Insights on the Growing Demand for Edible Coatings in Produce
• Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
• Legal Update: Toronto-Dominion Bank Securities Class Action
• Key Updates from Nasdaq on the Nasdaq-100 Index Changes
• TeraBox Revolutionizes File Sharing with Free Unlimited Service
• Kessler Topaz Takes Action Against Enphase Energy for Fraud
• Demesne Resources Completes Second Tranche of Financing
• Spiro Celebrated as One of the Top Agencies in Marketing
• Global Uranium Corp. Launches Strategic Marketing Efforts
• UnitedHealth Group Clarifies Misconceptions and Updates Claims
• Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
• Acadia Healthcare Investors Urged to Take Action on Lawsuit
• Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
• Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
• Hola Prime's Innovative Vision: New Marketing Director Appointed
• Teamsters Advocate for Stronger Standards on Autonomous Vehicles
• BioVaxys Secures Funding and Enters Debt Settlement Agreement
• Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
• OFS Credit Company Shares November Net Asset Value Insights
• New FDA Approval for Crenessity Enhances CAH Treatment Options